While muscle doesn’t weigh more than fat, it does have more volume. Muscle mass is leaner and more compact in comparison to fat. This makes muscle look different from fat on the body.

Building and maintaining muscle is emerging as a powerful strategy to improve longevity, research is revealing. Here's what Gabrielle Lyon, DO, wants you to know.

Discover how building muscle mass can reduce body fat by 4% and improve blood sugar control. Learn why strength training is essential for metabolic health and diabetes prevention.

Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women, and a high protein intake can mitigate this risk.

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side effect of weight loss drugs.

Many cancer survivors struggle with muscle weakness, which can be so profound that they may have difficulties walking up a couple of flights of stairs or going shopping for groceries on their own.

Researchers at Karolinska Institutet have discovered a previously unknown molecule that may explain why people with type 2 diabetes often suffer from muscle weakness and muscle loss—a condition ...

Author and registered dietician nutritionist Dawn Jackson Blatner joins John Williams to talk about the benefits of chocolate milk, why the natural sugar in fruit is so good for us, tips for a healthy ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat.

These foods high in protein help build muscle, particularly for those over 50. Adding them to your diet is a great way to maintain muscle mass with age.

Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in sales by 2035, analysts at ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full trial results for humans are expected later in 2025. Results from the Phase ...